R&D Incident Report Template - Compliance-Ready Template for Research & Development Organizations

Sep 13, 2026

Upload by Rhys

R&D Incident Report Template provides a compliance-ready structure for documenting research and development incidents from first discovery through reporting and archival. It includes document control fields, executive summary, reporting authority contacts, and regulatory notification status across FDA, EMA/national, OECD, data protection, IRB/ethics, and sponsors. It also standardizes incident classification (category, severity, regulatory impact, GLP deviation types), immediate response and containment actions, emergency notifications, and a detailed narrative with discovery, timeline, and study context placeholders.

LanguageEnglish

CategoryForms

FormatPDF

Pages23

Reading Time8 min

AccessFree to download

DOCUMENT CONTROL

1. COVER PAGE / EXECUTIVE SUMMARY

2. INCIDENT CLASSIFICATION

3. IMMEDIATE RESPONSE & CONTAINMENT

4. DETAILED INCIDENT DESCRIPTION

R&D INCIDENT REPORT TEMPLATE Compliance-Ready Template for Research & Development Organizations DOCUMENT CONTROL | Field | Details | | --- | --- | | Document ID | [TBD] | | Report Type | ☐ Initial Report ☐ Follow-up Report ☐ Final Report | | Report Date | [TBD] | | Incident Date/Time | [TBD] | | Discovery Date/Time | [TBD] | | Report Version | [TBD] | | Facility/Site | [TBD] | | Study/Project ID | [TBD] | | Regulatory Framework(s) | ☐ FDA 21 CFR Part 58 (GLP) ☐ FDA 21 CFR Part 820 (QSR) ☐ ISO 17025 ☐ ISO 45001 ☐ OECD GLP ☐ GDPR ☐ Other: [TBD] | 1. COVER PAGE / EXECUTIVE SUMMARY 1.1 Incident Title Brief Descriptive Title: [TBD] 1.2 Incident Summary Executive Summary (3-5 sentences): [TBD-Provide high-level overview of what occurred, immediate impact, and current status] 1.3 Reporting Authority | Role | Name | Contact | Date Notiﬁed | | --- | --- | --- | --- | | Incident Reporter | [TBD] | [TBD] | [TBD] | | Study Director/PI | [TBD] | [TBD] | [TBD] | | Quality Assurance Unit | [TBD] | [TBD] | [TBD] | | Management Representative | [TBD] | [TBD] | [TBD] | | Regulatory Aﬀairs | [TBD] | [TBD] | [TBD] | 1.4 Regulatory Notiﬁcation Status | Authority | Notiﬁcation Required? | Notiﬁcation Date | Reference Number | | --- | --- | --- | --- | | FDA | ☐ Yes ☐ No ☐ TBD | [TBD] | [TBD] | | EMA/National CA | ☐ Yes ☐ No ☐ TBD | [TBD] | [TBD] | | OECD | ☐ Yes ☐ No ☐ TBD | [TBD] | [TBD] | | Data Protection Authority | ☐ Yes ☐ No ☐ TBD | [TBD] | [TBD] | | IRB/Ethics Committee | ☐ Yes ☐ No ☐ TBD | [TBD] | [TBD] | | Sponsor | ☐ Yes ☐ No ☐ TBD | [TBD] | [TBD] | 2. INCIDENT CLASSIFICATION 2.1 Incident Category Primary Category: [Select one] - ☐ Protocol Deviation (GLP/GCP) - ☐ Equipment Failure/Malfunction - ☐ Data Integrity Issue - ☐ Safety/Occupational Health Incident - ☐ Environmental Release - ☐ Biological Product Deviation (21 CFR 600. 14) - ☐ Quality System Deviation (21 CFR 820) - ☐ Cybersecurity/IT Incident - ☐ Data Breach (GDPR) - ☐ Intellectual Property Breach - ☐ Conﬁdentiality Breach - ☐ Sample/Specimen Integrity - ☐ Documentation Error - ☐ Personnel/Training Issue - ☐ Facility/Infrastructure Issue - ☐ Supply Chain/Vendor Issue - ☐ Other: [TBD] Secondary Categories (if applicable): [TBD] 2.2 Severity Classiﬁcation Severity Level: [Select one] - ☐ Critical - Immediate threat to safety, data integrity, or regulatory compliance; product recall potential - ☐ Major-Signiﬁcant impact on study validity, safety, or compliance; requires immediate corrective action - ☐ Moderate-Noticeable impact but study integrity maintained; corrective action required - ☐ Minor-Limited impact; preventive action recommended - ☐ Negligible-No signiﬁcant impact; documentation only Justiﬁcation for Severity Rating: [TBD] 2.3 Regulatory Impact Assessment Does this incident aﬀect: | Impact Area | Yes/No | Details | |-----------------|------------|-------------| | Product safety, purity, or potency | ☐ Yes ☐ No | [TBD] || Study validity/integrity | ☐ Yes ☐ No | [TBD] | | Data reliability | ☐ Yes ☐ No | [TBD] || Regulatory submission | ☐ Yes ☐ No | [TBD] || Human subject safety | ☐ Yes ☐ No | [TBD] || Animal welfare | ☐ Yes ☐ No | [TBD] || Environmental compliance | ☐ Yes ☐ No | [TBD] || Occupational health & safety | ☐ Yes ☐ No | [TBD] | 2.4 GLP-Speciﬁc Classiﬁcation (21 CFR Part 58) GLP Deviation Type (if applicable): - ☐ Protocol deviation (§58 . 120) - ☐ Standard Operating Procedure (SOP) deviation (§58 .81) - ☐ Equipment failure (§58 .63) - ☐ Test/control article accountability issue (§58 .107 , §58 . 113) - ☐ Specimen/data handling deviation (§58 . 130) - ☐ Quality Assurance inspection ﬁnding (§58 .35) - ☐ Facility/environmental control issue (§58 .41-51) - ☐ Personnel qualiﬁcation issue (§58 .29) - ☐ Not applicable-Non-GLP study Study Phase at Time of Incident: - ☐ Pre-study ☐ In-life ☐ Post-dosing ☐ Data analysis ☐ Reporting ☐ Archival 3. IMM

FAQs

What sections are included in the R&D incident report template?

The template includes document control, cover page/executive summary, incident classification, immediate response and containment, and detailed incident description (discovery, timeline, narrative, and study/project context).

How does the template classify incident categories and severity?

It provides selectable incident categories (e.g., protocol deviation, equipment failure, data integrity issue) and a severity level with justification fields to record the impact on safety, data integrity, study validity, and compliance.

Which regulatory notification status can be recorded in this template?

The template includes notification requirements and reference numbers for FDA, EMA/national CA, OECD, data protection authority, IRB/ethics committee, and sponsor, along with notification dates.

Sep 13, 2026

Upload by Rhys